You are here

  • Home
  • Archive
  • Volume 17, Issue 2
  • Hammering the point home: serologic testing costs more and harms more patients than other strategies for the diagnosis of active tuberculosis in India

Alerts

Article menu
Download PDFPDF
Diagnosis
Cost effectiveness analysis
Hammering the point home: serologic testing costs more and harms more patients than other strategies for the diagnosis of active tuberculosis in India
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address